article · HIV & AIDS Review

Cost-effectiveness of antiretroviral regimens used in post-exposure prophylaxis program at United States’ PEPFAR-APIN clinics in a developing country: a retrospective pharmaco-economic analysis

Abdulmuminu Isah
Maxwell Ogochukwu Adibe
Chibueze Anosike
Nneka Uchenna Igboeli
Chinwe Victoria Ukwe
Kosisochi Chinwendu Amorha

2024Open accessUniversity of Nigeria

Abstract

An appropriate economic evaluation of post-exposure prophylaxis (PEP) should consider the effectiveness of different regimens prescribed for patients. Studies have not evaluated the comparative effectiveness of different PEP antiretrovirals (ARVs) based on their costs. Therefore, the aim of the present study was to determine the cost-effectiveness of ARVs regimens used for PEP in Nigerian tertiary hospitals.

Research topics

HIV/AIDS Research and Interventions
HIV/AIDS drug development and treatment
HIV-related health complications and treatments

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.5114/hivar.2024.135690

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.